As expected from the prevailing elevated iFGF23, Cyp24a1 mRNA was significantly increased in the CKD group, whereas EPO treatment had a trend toward reduced expression in these mice (Figure 2d). The gene discussed is EPO; the disease is chronic kidney disease.